AHR and COVID-19: Thus, a disturbed Trp metabolism involving increased proinflammatory activity of KA and possibly also FICZ and mediated by activation of the AhR and PARPs are likely to be at the centre of the pathophysiology of infectious diseases, including COVID-19.